Governance21 March 2025

New Members Elected to 星海棋牌鈥檚 Board of Directors

星海棋牌 employees have a unique opportunity to take part in corporate decision-making by electing representatives to the Board of Directors.

星海棋牌 employees have once again played a key role in shaping the company鈥檚 future through the recent election of new members to the Board of Directors. This ensures that diverse perspectives continue to contribute to corporate decision-making, reinforcing a culture of transparency, shared responsibility, and inclusivity in leadership.

At 星海棋牌, we believe in collaboration at all levels 鈥 not just in our science, but also in decision-making. Since 2010, 星海棋牌 employees have had the opportunity to serve as members of our Board of Directors, ensuring that employee voices contribute directly to shaping the future of the company.

Unlike many companies, 星海棋牌 offers employees a direct role in governance. Employee-elected Board members provide invaluable perspectives that enrich strategic discussions, drawing from their firsthand experience of the company culture and operations.

鈥淗aving employee representatives at the Board brings a unique perspective to all discussions; one that reflects, among other things, their first-hand knowledge of the company culture. By representing diverse groups, regions, and disciplines, they contribute with a valuable point of view to the strategy and operational discussions,鈥 says Board Chair Deirdre Connelly.

The Election Process and New Board Members


The employee board election took place from March 3-7, 2025, with employees casting their votes to elect three board members and three alternates. The newly elected board members are Martin Schultz, Senior Director, Clinical Operations, Mijke Zachariasse, Vice President, Head of Antibody Research Materials and Mike Kavanagh, Senior Director, Head of Strategic Engagement, Oncology Marketing, Marketing.

Martin Schultz, Senior Director, Clinical Operations, Mijke Zachariasse, Vice President, Head of Antibody Research Materials and Mike Kavanagh, Senior Director, Head of Strategic Engagement, Oncology Marketing, Marketing.
Martin Schultz, Senior Director, Clinical Operations, Mijke Zachariasse, Vice President, Head of Antibody Research Materials and Mike Kavanagh, Senior Director, Head of Strategic Engagement, Oncology Marketing, Marketing.

They will serve a three-year term, working closely with executive leadership to support 星海棋牌鈥檚 long-term strategy and drive continued innovation. Together, they bring valuable expertise and diverse perspectives that will strengthen the company鈥檚 leadership and governance.

"As the newly elected board members step into their roles, they will play a vital part in ensuring that 星海棋牌鈥檚 strategy is executed by top talent in an environment that reflects our core values," affirms Deirdre Connelly.